Quality-of-Life Measurement in Advanced Cancer: Assessing the Individual
作者： Dympna Waldron , Ciaran A. O'Boyle , Michael Kearney , Michael Moriarty , Desmond Carney
DOI: 10.1200/JCO.1999.17.11.3603
关键词: Advanced cancer 、 Internal consistency 、 Medicine 、 In patient 、 Quality of life 、 Internal validity 、 Surgery 、 Physical therapy 、 Incurable cancer 、 Quality of life scale 、 Psychometric data
摘要: PURPOSE: Despite the increasing importance of assessing quality life (QoL) in patients with advanced cancer, relatively little is known about individual patient's perceptions issues contributing to their QoL. The Schedule for Evaluation Individual Quality Life (SEIQoL) and shorter SEIQoL–Direct Weighting (SEIQoL-DW) assess individualized QoL using a semistructured interview technique. Here we report findings from first administration SEIQoL SEIQoL-DW incurable cancer. PATIENTS AND METHODS: was assessed on single occasion 80 RESULTS: All were able complete SEIQoL-DW, 78% completed SEIQoL. Of possible score 100, median global as follows: SEIQoL, 61 (range, 24 94); 60.5 6 95). Psychometric data indicated very high levels internal consistency (median r = .90) validity ...
sci-hub.se 参考文章(49)
NM Bleehen, , DJ Girling, D Machin, RJ Stephens, A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party. British Journal of Cancer. ,vol. 68, pp. 1157- 1166 ,(1993) , 10.1038/BJC.1993.497
John P Browne, Ciaran A O‘Boyle, Hannah M McGee, Nicholas J McDonald, C. R. B Joyce, Development of a direct weighting procedure for quality of life domains. Quality of Life Research. ,vol. 6, pp. 301- 309 ,(1997) , 10.1023/A:1018423124390
Bert Spilker, Quality of life and pharmacoeconomics in clinical trials Lippincott-Raven. ,(1996)
Walter O. Spitzer, Annette J. Dobson, Jane Hall, Esther Chesterman, John Levi, Richard Shepherd, Renaldo N. Battista, Barry R. Catchlove, Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. Journal of Chronic Diseases. ,vol. 34, pp. 585- 597 ,(1981) , 10.1016/0021-9681(81)90058-8
I F Tannock, D Osoba, M R Stockler, D S Ernst, A J Neville, M J Moore, G R Armitage, J J Wilson, P M Venner, C M Coppin, K C Murphy, Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. Journal of Clinical Oncology. ,vol. 14, pp. 1756- 1764 ,(1996) , 10.1200/JCO.1996.14.6.1756
J A Sloan, C L Loprinzi, S A Kuross, A W Miser, J R O'Fallon, M R Mahoney, I M Heid, M E Bretscher, N L Vaught, Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Journal of Clinical Oncology. ,vol. 16, pp. 3662- 3673 ,(1998) , 10.1200/JCO.1998.16.11.3662
David L Sackett, William M C Rosenberg, The need for evidence-based medicine. Journal of the Royal Society of Medicine. ,vol. 88, pp. 620- 624 ,(1995) , 10.1177/014107689508801105
JCJM de Haes, FCE van Knippenberg, JP Neijt, Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer. ,vol. 62, pp. 1034- 1038 ,(1990) , 10.1038/BJC.1990.434
C. R. B. Joyce, Health status and quality of life: which matters to the patient? Journal of Cardiovascular Pharmacology. ,vol. 23, ,(1994) , 10.1097/00005344-199400233-00006
Alan Coates, Val Gebski, James F. Bishop, Peter N. Jeal, Robert L. Woods, Raymond Snyder, Martin H.N. Tattersall, Michael Byrne, Vernon Harvey, Grantley Gill, John Simpson, Roslyn Drummond, Judy Browne, Rodney van Cooten, John F. Forbes, , Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. The New England Journal of Medicine. ,vol. 317, pp. 1490- 1495 ,(1987) , 10.1056/NEJM198712103172402